Antibiotic drop efficacy trial
A proof-of-principle, prospective, open label, randomised, controlled, parallel design, one-month clinical trial to determine if prophylactic instillation of antibiotic drops during continuous wear of silicone hydrogel contact lenses reduces the incidence of contact lens related ocular inflammatory adverse events.
Brien Holden Vision Institute
240 participants
Nov 1, 2010
Interventional
Conditions
Summary
The objective of this proff of principle trial is to determine if prophylactic antibiotic drop used during continuous wear of silicone hydrogel contact lenses reduces the incidence of contact lens related inflammatory ocular adverse events.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Test group will be randomised to instil Moxifloxacin antibiotic drops twice a day into each eye on waking and prior to sleep (in the evening). Commercially available siliconhydrogel lenses are to be worn on a continuous wear basis (that is, during the day and night) for approximately I month
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12610000920099